Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach

2021/09/30 by Sandrine M. Caputo, Lisa Golmard, Mélanie Léoné +178 · 16 citations
Biochemistry, Genetics and Molecular Biology · #BRCA gene mutations in cancer #CRISPR and Genetic Engineering #Cancer Genomics and Diagnostics

paper · pdf · doi:10.1016/j.ajhg.2021.09.003

Cited by

• Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance. [europepmc]
• The Challenge of Genetic Variants of Uncertain Clinical Significance : A Narrative Review. [europepmc]
• Understanding and predicting the functional consequences of missense mutations in BRCA1 and BRCA2. [europepmc]
• A Comprehensive Evaluation of the Performance of Prediction Algorithms on Clinically Relevant Missense Variants. [europepmc]
• Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients. [europepmc]
• Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort. [europepmc]
• Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing. [europepmc]
• Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management. [europepmc]
• Whole-exome sequencing and Drosophila modelling reveal mutated genes and pathways contributing to human ovarian failure. [europepmc]
• Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1 / BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system. [europepmc]
• RNA Panel Sequencing Is an Effective Tool to Help Classify Splice Variants for Clinical Oncogenetic Diagnosis. [europepmc]
• Precision screening facilitates clinical classification of BRCA2-PALB2 binding variants with benign and pathogenic functional effects. [europepmc]
• A founder BRCA1 exonic duplication involving breakpoint in T2T reference genome-specific region results in constitutional fusion transcript. [europepmc]
• TP53 c.730G > A pathogenic variant as a plausible candidate biomarker in pancreatic ductal adenocarcinoma patients from Karachi, pakistan: a retrospective cohort study. [europepmc]
• Germline BRCA1/2 Variants in Polish Patients with Family History of Breast and Ovarian Cancer: Prevalence, CNV Detection, and Identification of a Novel Loss-of-Function Mutation. [europepmc]
• Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification. [europepmc]